More on LYEL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.4 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lyell Immunopharma (NQ:LYEL)
Delayed: 9.39 +0.01 (0.11%)
Prev. Close $9.38  
Open$9.33 
52 Wk High$ 
52 Wk Low$ 
Day High$9.45 
Day Low$9.05 
P/E N/A  
EPS$ 
Volume101,638 

Friends, Peers and Foes (?): CRBU, GTBP, NRIX, SLS PRQR (more...)

Oct 13, 2026 05:18 PM Form 4 Lyell Immunopharma, Inc. For: Oct 12 Filed by: Aguirre Jarrad Mattieu
Sep 14, 2026 07:00 AM Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
Sep 11, 2026 07:00 AM H.C. Wainwright Reiterates Buy Rating on Lyell Immunopharma (LYEL)
Sep 10, 2026 07:38 PM Form 4 Lyell Immunopharma, Inc. For: Sep 10 Filed by: Shook David
Sep 10, 2026 07:32 PM Form 4 Lyell Immunopharma, Inc. For: Sep 10 Filed by: Aguirre Jarrad Mattieu
Sep 10, 2026 07:30 PM Form 3 Lyell Immunopharma, Inc. For: Aug 31 Filed by: Aguirre Jarrad Mattieu
Sep 10, 2026 04:14 PM Form 8-K Lyell Immunopharma, Inc. For: Sep 10
Sep 10, 2026 04:05 PM Lyell shifts LYL273 trial timeline, eyes 2027 FDA meeting
Sep 10, 2026 04:05 PM Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
Aug 25, 2026 04:07 PM Form 4 Lyell Immunopharma, Inc. For: Aug 21 Filed by: Seely Lynn
View All Articles

Entities mentioned with LYEL

View All Entities